BioAge Labs, Inc.
Status: Publicly traded
Direct answer
BioAge Labs, Inc. is publicly traded on NASDAQ under the ticker BIOA.
BioAge Labs, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for metabolic illnesses. The company employs a distinctive technology platform alongside specialized human datasets to pinpoint potential drug targets by unraveling the molecular mechanisms underlying the aging process. Their current pipeline features azelaprag, an oral small molecule, which is...
Can you invest in BioAge Labs, Inc.?
Yes. BioAge Labs, Inc. is publicly traded on NASDAQ under the ticker BIOA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for BioAge Labs, Inc.
Detailed equity research is provided by MarketSnap.